In July 2026, the European stock market has been navigating a complex landscape marked by volatility in tech stocks and fluctuating oil prices, with the pan-European STOXX Europe 600 Index ending a turbulent week nearly unchanged. Amid this backdrop, investors are keenly assessing opportunities to identify stocks that may be trading below their intrinsic value, focusing on companies with strong fundamentals and potential for growth despite broader market challenges.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name	Current Price	Fair Value (Est)	Discount (Est)
PCC Rokita (WSE:PCR)	PLN71.80	PLN142.17	49.5%
Netcompany Group (CPSE:NETC)	DKK304.40	DKK605.89	49.8%
Micro Systemation (OM:MSAB B)	SEK86.20	SEK172.07	49.9%
Laboratorios Farmaceuticos Rovi (BME:ROVI)	€54.70	€109.13	49.9%
Hiab Oyj (HLSE:HIAB)	€53.25	€106.46	50%
F-Secure Oyj (HLSE:FSECURE)	€1.90	€3.80	50%
Deutsche Beteiligungs (XTRA:DBAN)	€21.90	€43.48	49.6%
Com.Tel (BIT:CMTL)	€1.86	€3.70	49.7%
Casta Diva Group (BIT:CDG)	€3.06	€6.06	49.5%
Cambi (OB:CAMBI)	NOK21.50	NOK42.59	49.5%

Click here to see the full list of 208 stocks from our Undervalued European Stocks Based On Cash Flows screener.

We're going to check out a few of the best picks from our screener tool.

CTT - Correios De Portugal (ENXTLS:CTT)

Overview: CTT - Correios De Portugal, S.A., along with its subsidiaries, operates in the postal sector both in Portugal and internationally, with a market cap of €788.81 million.

Operations: The company generates revenue through several segments, including Banco CTT (€148.33 million), Mail and Services (€511.89 million), and E-Commerce Solutions (€668.67 million).

Estimated Discount To Fair Value: 40.2%

CTT - Correios De Portugal is trading at €5.98, significantly below its estimated future cash flow value of €9.99, suggesting it may be undervalued based on cash flows. Despite an unstable dividend track record, CTT's earnings are forecast to grow 17.52% annually, outpacing the Portuguese market's growth rate of 11.5%. Recent earnings showed increased revenue but a slight decline in net income compared to the previous year, highlighting areas for potential improvement.

• Our expertly prepared growth report on CTT - Correios De Portugal implies its future financial outlook may be stronger than recent results.
• Click here to discover the nuances of CTT - Correios De Portugal with our detailed financial health report.

Idorsia (SWX:IDIA)

Overview: Idorsia Ltd is a biopharmaceutical company focused on discovering, developing, and commercializing drugs for unmet medical needs across several regions including Switzerland, the United States, Japan, Europe, China, and Canada; it has a market cap of CHF1.61 billion.

Operations: The company's revenue primarily comes from its innovative medicines segment, generating CHF219.10 million.

Estimated Discount To Fair Value: 43.1%

Idorsia is trading at CHF6.3, considerably below its estimated future cash flow value of CHF11.08, indicating potential undervaluation based on cash flows. Despite recent shareholder dilution and high share price volatility, earnings are forecast to grow 72.91% annually with revenue growth expected to outpace the Swiss market significantly. Recent debt refinancing has improved liquidity and reduced near-term maturities, while strategic executive changes aim to enhance commercial performance and long-term growth prospects.

• According our earnings growth report, there's an indication that Idorsia might be ready to expand.
• Delve into the full analysis health report here for a deeper understanding of Idorsia.

PCC Rokita (WSE:PCR)

Overview: PCC Rokita SA is a chemical company that designs, produces, and sells products across various regions including Poland, Germany, the European Union, the United States, Asia, and other international markets with a market cap of PLN1.45 billion.

Operations: The company's revenue segments include Polyurethanes at PLN692.36 million, Organochlorine at PLN839.48 million, Power Industry at PLN182.12 million, and Other Chemical Activities at PLN168.69 million.

Estimated Discount To Fair Value: 49.5%

PCC Rokita is trading at PLN71.8, significantly below its estimated future cash flow value of PLN142.17, highlighting potential undervaluation. Despite a challenging quarter with sales dropping to PLN432.1 million and a net loss of PLN5.56 million, earnings are projected to grow over 20% annually, outpacing the Polish market's growth rate. However, profit margins have declined and the dividend yield of 3.69% isn't well covered by earnings, raising sustainability concerns amidst large one-off items affecting financial results.

• In light of our recent growth report, it seems possible that PCC Rokita's financial performance will exceed current levels.
• Dive into the specifics of PCC Rokita here with our thorough financial health report.

Turning Ideas Into Actions

• Navigate through the entire inventory of 208 Undervalued European Stocks Based On Cash Flows here.
• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.